Massachusetts Financial Services’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.3M | Buy |
487,961
+67,916
| +16% | +$2.96M | 0.01% | 609 |
|
|
2025
Q1 | $11.5M | Buy |
420,045
+555
| +0.1% | +$15.2K | ﹤0.01% | 650 |
|
|
2024
Q4 | $16.9M | Sell |
419,490
-33,887
| -7% | -$1.36M | 0.01% | 618 |
|
|
2024
Q3 | $21.5M | Buy |
453,377
+47,507
| +12% | +$2.25M | 0.01% | 584 |
|
|
2024
Q2 | $12.1M | Buy |
405,870
+10,731
| +3% | +$320K | ﹤0.01% | 624 |
|
|
2024
Q1 | $15.9M | Sell |
395,139
-67,536
| -15% | -$2.71M | ﹤0.01% | 596 |
|
|
2023
Q4 | $11.8M | Sell |
462,675
-858
| -0.2% | -$21.8K | ﹤0.01% | 611 |
|
|
2023
Q3 | $6.44M | Buy |
463,533
+86,585
| +23% | +$1.2M | ﹤0.01% | 642 |
|
|
2023
Q2 | $8.67M | Buy |
376,948
+37,801
| +11% | +$869K | ﹤0.01% | 614 |
|
|
2023
Q1 | $10M | Buy |
+339,147
| New | +$10M | ﹤0.01% | 608 |
|